Last 12 months
Inside the activity.
1 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 31, 2023 Filed Apr 3, 2023 20:51 UTC |
SMITH PATRICK FPRESIDENT, INTEGRATED DRUG DEV
|
Tax withholdingCommon Stock | 1,532 | $23.80 | $36,461.60 |
DisclosureSEC source: 0001415889-23-005808 · form4-04032023_080426.xml · nonDerivative · entry 1 SMITH PATRICK F · CIK 0001890360 · PRESIDENT, INTEGRATED DRUG DEV 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,327 F1 · shares: Represents restricted stock units ("RSUs") withheld to satisfy the tax withholding obligations in connection with the vesting and settlement of RSUs, exempt under Rule 16b-3. Each RSUs was granted on April 1, 2021, under the Certara, Inc. 2020 Incentive Plan (the "2020 Incentive Plan") and represents a right to receive one share of common stock or the cash equivalent thereof. One-third of the RSUs vested and were settled on April 1, 2022. One-third of the RSUs vested and were on March 31, 2023. The remaining one-third of the RSUs are scheduled to vest and settle on April 1, 2024. F2 · balance_after: The total reported in Column 5 includes 4,884 RSUs which was previously reported in Table 1 of Form 4. Read SEC document |
| March 31, 2023 Filed Apr 3, 2023 20:49 UTC |
Traynor Richard M.SVP AND GENERAL COUNSEL
|
Exercise / conversionRestricted Stock Units · Derivative | 6,651 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-005805 · form4-04032023_080427.xml · derivative · entry 4 Traynor Richard M. · CIK 0001834465 · SVP AND GENERAL COUNSEL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,302 Underlying: Common Stock · 6,651 shares Expires 2025-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU was granted on April 1, 2022, under the 2020 Incentive Plan and represents a right to receive one share of common stock or the cash equivalent thereof. One-third of the RSUs vested and were settled on March 31, 2023. The remaining two-thirds of the RSUs are scheduled to vest and settle in two equal installments on April 1, 2024, and April 1, 2025. F3 · derivative.exercise_date: Each RSU was granted on April 1, 2022, under the 2020 Incentive Plan and represents a right to receive one share of common stock or the cash equivalent thereof. One-third of the RSUs vested and were settled on March 31, 2023. The remaining two-thirds of the RSUs are scheduled to vest and settle in two equal installments on April 1, 2024, and April 1, 2025. Read SEC document |
| March 31, 2023 Filed Apr 3, 2023 20:49 UTC |
Traynor Richard M.SVP AND GENERAL COUNSEL
|
Tax withholdingCommon Stock | 2,124 | $23.80 | $50,551.20 |
DisclosureSEC source: 0001415889-23-005805 · form4-04032023_080427.xml · nonDerivative · entry 3 Traynor Richard M. · CIK 0001834465 · SVP AND GENERAL COUNSEL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 187,368 F4 · shares: Represents RSUs withheld to satisfy the tax withholding obligations in connection with the vesting and settlement of RSUs, exempt under Rule 16b-3. F2 · balance_after: The total reported in Column 5 includes 5,495 RSUs which was previously reported in Table 1 of Form 4. Read SEC document |
| March 31, 2023 Filed Apr 3, 2023 20:49 UTC |
Traynor Richard M.SVP AND GENERAL COUNSEL
|
Exercise / conversionCommon Stock | 6,651 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-005805 · form4-04032023_080427.xml · nonDerivative · entry 2 Traynor Richard M. · CIK 0001834465 · SVP AND GENERAL COUNSEL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 189,492 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: Each RSU was granted on April 1, 2022, under the 2020 Incentive Plan and represents a right to receive one share of common stock or the cash equivalent thereof. One-third of the RSUs vested and were settled on March 31, 2023. The remaining two-thirds of the RSUs are scheduled to vest and settle in two equal installments on April 1, 2024, and April 1, 2025. F2 · balance_after: The total reported in Column 5 includes 5,495 RSUs which was previously reported in Table 1 of Form 4. Read SEC document |
| March 31, 2023 Filed Apr 3, 2023 20:49 UTC |
Traynor Richard M.SVP AND GENERAL COUNSEL
|
Tax withholdingCommon Stock | 1,723 | $23.80 | $41,007.40 |
DisclosureSEC source: 0001415889-23-005805 · form4-04032023_080427.xml · nonDerivative · entry 1 Traynor Richard M. · CIK 0001834465 · SVP AND GENERAL COUNSEL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 182,841 F1 · shares: Represents restricted stock units ("RSUs") withheld to satisfy the tax withholding obligations in connection with the vesting and settlement of RSUs, exempt under Rule 16b-3. Each RSUs was granted on April 1, 2021, under the Certara, Inc. 2020 Incentive Plan (the "2020 Incentive Plan") and represents a right to receive one share of common stock or the cash equivalent thereof. One-third of the RSUs vested and were settled on April 1, 2022. One-third of the RSUs vested and were on March 31, 2023. The remaining one-third of the RSUs are scheduled to vest and settle on April 1, 2024. F2 · balance_after: The total reported in Column 5 includes 5,495 RSUs which was previously reported in Table 1 of Form 4. Read SEC document |
| March 31, 2023 Filed Apr 3, 2023 20:42 UTC |
Aspbury RobertPRESIDENT, SIMCYP
|
Exercise / conversionRestricted Stock Units · Derivative | 8,646 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-005801 · form4-04032023_080407.xml · derivative · entry 4 Aspbury Robert · CIK 0001834221 · PRESIDENT, SIMCYP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,293 Underlying: Common Stock · 8,646 shares Expires 2025-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU was granted on April 1, 2022, under the 2020 Incentive Plan and represents a right to receive one share of common stock or the cash equivalent thereof. One-third of the RSUs vested and were settled on March 31, 2023. The remaining two-thirds of the RSUs are scheduled to vest and settle in two equal installments on April 1, 2024, and April 1, 2025. F3 · derivative.exercise_date: Each RSU was granted on April 1, 2022, under the 2020 Incentive Plan and represents a right to receive one share of common stock or the cash equivalent thereof. One-third of the RSUs vested and were settled on March 31, 2023. The remaining two-thirds of the RSUs are scheduled to vest and settle in two equal installments on April 1, 2024, and April 1, 2025. Read SEC document |
| March 31, 2023 Filed Apr 3, 2023 20:42 UTC |
Aspbury RobertPRESIDENT, SIMCYP
|
Tax withholdingCommon Stock | 4,064 | $23.80 | $96,723.20 |
DisclosureSEC source: 0001415889-23-005801 · form4-04032023_080407.xml · nonDerivative · entry 3 Aspbury Robert · CIK 0001834221 · PRESIDENT, SIMCYP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 276,927 F4 · shares: Represents RSUs withheld to satisfy the tax withholding obligations in connection with the vesting and settlement of RSUs, exempt under Rule 16b-3. F2 · balance_after: The total reported in Column 5 includes 9,769 RSUs which was previously reported in Table 1 of Form 4. Read SEC document |
| March 31, 2023 Filed Apr 3, 2023 20:42 UTC |
Aspbury RobertPRESIDENT, SIMCYP
|
Exercise / conversionCommon Stock | 8,646 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-005801 · form4-04032023_080407.xml · nonDerivative · entry 2 Aspbury Robert · CIK 0001834221 · PRESIDENT, SIMCYP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 280,991 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: Each RSU was granted on April 1, 2022, under the 2020 Incentive Plan and represents a right to receive one share of common stock or the cash equivalent thereof. One-third of the RSUs vested and were settled on March 31, 2023. The remaining two-thirds of the RSUs are scheduled to vest and settle in two equal installments on April 1, 2024, and April 1, 2025. F2 · balance_after: The total reported in Column 5 includes 9,769 RSUs which was previously reported in Table 1 of Form 4. Read SEC document |
| March 31, 2023 Filed Apr 3, 2023 20:42 UTC |
Aspbury RobertPRESIDENT, SIMCYP
|
Tax withholdingCommon Stock | 2,870 | $23.80 | $68,306.00 |
DisclosureSEC source: 0001415889-23-005801 · form4-04032023_080407.xml · nonDerivative · entry 1 Aspbury Robert · CIK 0001834221 · PRESIDENT, SIMCYP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 272,345 F1 · shares: Represents restricted stock units ("RSUs") withheld to satisfy the tax withholding obligations in connection with the vesting and settlement of RSUs, exempt under Rule 16b-3. Each RSUs was granted on April 1, 2021, under the Certara, Inc. 2020 Incentive Plan (the "2020 Incentive Plan") and represents a right to receive one share of common stock or the cash equivalent thereof. One-third of the RSUs vested and were settled on April 1, 2022. One-third of the RSUs vested and were on March 31, 2023. The remaining one-third of the RSUs are scheduled to vest and settle on April 1, 2024. F2 · balance_after: The total reported in Column 5 includes 9,769 RSUs which was previously reported in Table 1 of Form 4. Read SEC document |
| March 31, 2023 Filed Apr 3, 2023 20:40 UTC |
Schemick Michael AndrewCHIEF FINANCIAL OFFICER
|
Exercise / conversionRestricted Stock Units · Derivative | 13,302 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-005799 · form4-04032023_080439.xml · derivative · entry 4 Schemick Michael Andrew · CIK 0001834300 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,604 Underlying: Common Stock · 13,302 shares Expires 2025-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU was granted on April 1, 2022, under the 2020 Incentive Plan and represents a right to receive one share of common stock or the cash equivalent thereof. One-third of the RSUs vested and were settled on March 31, 2023. The remaining two-thirds of the RSUs are scheduled to vest and settle in two equal installments on April 1, 2024, and April 1, 2025. F3 · derivative.exercise_date: Each RSU was granted on April 1, 2022, under the 2020 Incentive Plan and represents a right to receive one share of common stock or the cash equivalent thereof. One-third of the RSUs vested and were settled on March 31, 2023. The remaining two-thirds of the RSUs are scheduled to vest and settle in two equal installments on April 1, 2024, and April 1, 2025. Read SEC document |
| March 31, 2023 Filed Apr 3, 2023 20:40 UTC |
Schemick Michael AndrewCHIEF FINANCIAL OFFICER
|
Tax withholdingCommon Stock | 4,556 | $23.80 | $108,432.80 |
DisclosureSEC source: 0001415889-23-005799 · form4-04032023_080439.xml · nonDerivative · entry 3 Schemick Michael Andrew · CIK 0001834300 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 522,895 F4 · kind: Represents RSUs withheld to satisfy the tax withholding obligations in connection with the vesting and settlement of RSUs, exempt under Rule 16b-3. F2 · balance_after: The total reported in Column 5 includes 11,600 RSUs which was previously reported in Table 1 of Form 4. Read SEC document |
| March 31, 2023 Filed Apr 3, 2023 20:40 UTC |
Schemick Michael AndrewCHIEF FINANCIAL OFFICER
|
Exercise / conversionCommon Stock | 13,302 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-23-005799 · form4-04032023_080439.xml · nonDerivative · entry 2 Schemick Michael Andrew · CIK 0001834300 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 527,451 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Each RSU was granted on April 1, 2022, under the 2020 Incentive Plan and represents a right to receive one share of common stock or the cash equivalent thereof. One-third of the RSUs vested and were settled on March 31, 2023. The remaining two-thirds of the RSUs are scheduled to vest and settle in two equal installments on April 1, 2024, and April 1, 2025. F2 · balance_after: The total reported in Column 5 includes 11,600 RSUs which was previously reported in Table 1 of Form 4. Read SEC document |
| March 31, 2023 Filed Apr 3, 2023 20:40 UTC |
Schemick Michael AndrewCHIEF FINANCIAL OFFICER
|
Tax withholdingCommon Stock | 3,721 | $23.80 | $88,559.80 |
DisclosureSEC source: 0001415889-23-005799 · form4-04032023_080439.xml · nonDerivative · entry 1 Schemick Michael Andrew · CIK 0001834300 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 514,149 F1 · kind: Represents restricted stock units ("RSUs") withheld to satisfy the tax withholding obligations in connection with the vesting and settlement of RSUs, exempt under Rule 16b-3. Each RSUs was granted on April 1, 2021, under the Certara, Inc. 2020 Incentive Plan (the "2020 Incentive Plan") and represents a right to receive one share of common stock or the cash equivalent thereof. One-third of the RSUs vested and were settled on April 1, 2022. One-third of the RSUs vested and were on March 31, 2023. The remaining one-third of the RSUs are scheduled to vest and settle on April 1, 2024. F1 · shares: Represents restricted stock units ("RSUs") withheld to satisfy the tax withholding obligations in connection with the vesting and settlement of RSUs, exempt under Rule 16b-3. Each RSUs was granted on April 1, 2021, under the Certara, Inc. 2020 Incentive Plan (the "2020 Incentive Plan") and represents a right to receive one share of common stock or the cash equivalent thereof. One-third of the RSUs vested and were settled on April 1, 2022. One-third of the RSUs vested and were on March 31, 2023. The remaining one-third of the RSUs are scheduled to vest and settle on April 1, 2024. F2 · balance_after: The total reported in Column 5 includes 11,600 RSUs which was previously reported in Table 1 of Form 4. Read SEC document |
| March 06, 2023 Filed Mar 7, 2023 21:35 UTC |
Traynor Richard M.SVP AND GENERAL COUNSEL
|
SaleCommon Stock | 10,000 | $21.45 | $214,500.00 |
DisclosureSEC source: 0001415889-23-004425 · form4-03072023_090323.xml · nonDerivative · entry 1 Traynor Richard M. · CIK 0001834465 · SVP AND GENERAL COUNSEL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 184,564 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 11, 2022. Read SEC document |
| February 02, 2023 Filed Feb 3, 2023 21:40 UTC |
Traynor Richard M.SVP AND GENERAL COUNSEL
|
SaleCommon Stock | 15,000 | $20.00 | $300,000.00 |
DisclosureSEC source: 0001415889-23-001930 · form4-02032023_090209.xml · nonDerivative · entry 1 Traynor Richard M. · CIK 0001834465 · SVP AND GENERAL COUNSEL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 194,564 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 11, 2022. Read SEC document |
| December 08, 2022 Filed Dec 12, 2022 21:16 UTC |
EQT Avatar Parent L.P.10% owner
EQT Avatar Parent GP LLC10% owner
EQT Fund Management S.a r.l.10% owner
|
SaleCommon Stock | 29,954,521 | $15.00 | $449,317,815.00 |
DisclosureSEC source: 0001104659-22-126283 · tm2232484-1_4seq1.xml · nonDerivative · entry 1 EQT Avatar Parent L.P. · CIK 0001715533 · 10% owner EQT Avatar Parent GP LLC · CIK 0001833933 · 10% owner EQT Fund Management S.a r.l. · CIK 0001834239 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Held by EQT Avatar Parent L.P. Disclosed balance after: 0 F1 · price: The sale was executed in a single block trade at $15.00 per share. F2 · ownership.nature: Consists of shares of common stock held directly by EQT Avatar Parent L.P. ("EQT Investor"). EQT Avatar Parent GP LLC ("Avatar Parent GP") is the general partner of the EQT Investor. Several investment vehicles collectively make up the fund known as "EQT VII." EQT VII owns 100% of the membership interests in Avatar Parent GP. EQT Fund Management S.a r.l. ("EFMS") has exclusive responsibility for the management and control of the business and affairs of investment vehicles which constitute the majority of the total commitments to EQT VII. As such, EFMS has the power to control Avatar Parent GP's voting and investment decisions and may be deemed to have beneficial ownership of the securities held by the EQT Investor. Read SEC document |
| November 22, 2022 Filed Nov 23, 2022 21:54 UTC |
Pedersen Leif EPRESIDENT, SOFTWARE
|
SaleCommon Stock | 51,223 | $15.55 | $796,517.65 |
DisclosureSEC source: 0001415889-22-011748 · form4-11232022_091140.xml · nonDerivative · entry 1 Pedersen Leif E · CIK 0001559712 · PRESIDENT, SOFTWARE 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,500 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 23, 2022. F2 · price: This transaction was executed in multiple trades at prices ranging from $15.28 to $15.69. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 15, 2022 Filed Nov 16, 2022 16:27 UTC |
SLAINE MASON PDirector
|
SaleCommon Stock | 245,793 | $15.57 | $3,826,997.01 |
DisclosureSEC source: 0001415889-22-011442 · form4-11162022_091140.xml · nonDerivative · entry 2 SLAINE MASON P · CIK 0001079093 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 660,322 F2 · price: This transaction was executed in multiple trades at prices ranging from $15.25 to $15.81. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 14, 2022 Filed Nov 15, 2022 21:50 UTC |
WALSH MATTHEW MDirector
|
SaleCommon Stock | 12,059 | $14.74 | $177,749.66 |
DisclosureSEC source: 0001415889-22-011400 · form4-11152022_091148.xml · nonDerivative · entry 1 WALSH MATTHEW M · CIK 0001269428 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 167,901 F1 · price: This transaction was executed in multiple trades at prices ranging from $14.66 to $14.88. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 14, 2022 Filed Nov 16, 2022 16:27 UTC |
SLAINE MASON PDirector
|
SaleCommon Stock | 4,207 | $15.27 | $64,240.89 |
DisclosureSEC source: 0001415889-22-011442 · form4-11162022_091140.xml · nonDerivative · entry 1 SLAINE MASON P · CIK 0001079093 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 906,115 F1 · price: This transaction was executed in multiple trades at prices ranging from $15.25 to $15.32. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 09, 2022 Filed Nov 14, 2022 21:33 UTC |
SMITH PATRICK FPRESIDENT, INTEGRATED DRUG DEV
|
SaleCommon Stock | 2,387 | $13.48 | $32,176.76 |
DisclosureSEC source: 0001415889-22-011348 · form4-11142022_091110.xml · nonDerivative · entry 1 SMITH PATRICK F · CIK 0001890360 · PRESIDENT, INTEGRATED DRUG DEV 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,859 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 5, 2022. Read SEC document |
| November 01, 2022 Filed Nov 2, 2022 20:57 UTC |
SMITH PATRICK FPRESIDENT, INTEGRATED DRUG DEV
|
Tax withholdingCommon Stock | 1,244 | $12.23 | $15,214.12 |
DisclosureSEC source: 0001415889-22-011013 · form4-11022022_011117.xml · nonDerivative · entry 1 SMITH PATRICK F · CIK 0001890360 · PRESIDENT, INTEGRATED DRUG DEV 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,246 F1 · shares: Represents restricted stock units ("RSUs") withheld to satisfy the tax withholding obligations in connection with the vesting and settlement of 3,631 RSUs. The RSUs were granted on November 1, 2021, subject to one-year cliff vesting. F2 · balance_after: The total reported in column 5 includes 45,404 shares of common stock, 22,074 restricted stock and 9,768 RSUs, each of which was previously reported in Table 1 of Form 4. Read SEC document |
| October 04, 2022 Filed Oct 6, 2022 20:31 UTC |
Virkler DraytonINTERIM PRESIDENT, REG & ACCES
|
GrantRestricted Stock Units · Derivative | 17,440 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-010383 · form4-10062022_011002.xml · derivative · entry 1 Virkler Drayton · CIK 0001945604 · INTERIM PRESIDENT, REG & ACCES 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,440 Underlying: Common Stock · 17,440 shares Expires 2025-10-04 F1 · derivative.exercise_price: Each restricted stock unit ("RSU") was granted under the Certara, Inc. 2020 Incentive Plan and represents a right to receive one share of common stock or the cash equivalent thereof. F2 · derivative.exercise_date: The RSUs are scheduled to vest and settle in three equal installments on October 4, 2023, October 4, 2024, and October 4, 2025. Read SEC document |
| September 30, 2022 Filed Oct 4, 2022 21:05 UTC |
Virkler DraytonINTERIM PRESIDENT, REG & ACCES
|
Exercise / conversionRestricted Stock Units · Derivative | 3,021 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-010245 · form4-10042022_021054.xml · derivative · entry 5 Virkler Drayton · CIK 0001945604 · INTERIM PRESIDENT, REG & ACCES 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,042 Underlying: Common Stock · 3,021 shares Expires 2024-10-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU was granted under the Certara, Inc. 2020 Incentive Plan and represents a right to receive one share of common stock or the cash equivalent thereof. One-third of the RSUs vested and were settled on September 30, 2022. The remaining two-thirds of the RSUs are scheduled to vest and settle on October 1, 2023 and October 1, 2024, subject to the continued service of the reporting person. F2 · derivative.exercise_date: Each RSU was granted under the Certara, Inc. 2020 Incentive Plan and represents a right to receive one share of common stock or the cash equivalent thereof. One-third of the RSUs vested and were settled on September 30, 2022. The remaining two-thirds of the RSUs are scheduled to vest and settle on October 1, 2023 and October 1, 2024, subject to the continued service of the reporting person. Read SEC document |
| September 30, 2022 Filed Oct 4, 2022 21:05 UTC |
Virkler DraytonINTERIM PRESIDENT, REG & ACCES
|
Exercise / conversionRestricted Stock Units · Derivative | 10,574 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-010245 · form4-10042022_021054.xml · derivative · entry 4 Virkler Drayton · CIK 0001945604 · INTERIM PRESIDENT, REG & ACCES 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,574 shares Expires 2022-10-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSUs") was granted under the Certara, Inc. 2020 Incentive Plan and represents a right to receive one share of common stock or the cash equivalent thereof. The RSUs were granted on October 1, 2021 and cliff vested and settled on September 30, 2022. F1 · derivative.exercise_date: Each restricted stock unit ("RSUs") was granted under the Certara, Inc. 2020 Incentive Plan and represents a right to receive one share of common stock or the cash equivalent thereof. The RSUs were granted on October 1, 2021 and cliff vested and settled on September 30, 2022. Read SEC document |
| September 30, 2022 Filed Oct 4, 2022 21:05 UTC |
Virkler DraytonINTERIM PRESIDENT, REG & ACCES
|
Tax withholdingCommon stock | 4,004 | $13.31 | $53,293.24 |
DisclosureSEC source: 0001415889-22-010245 · form4-10042022_021054.xml · nonDerivative · entry 3 Virkler Drayton · CIK 0001945604 · INTERIM PRESIDENT, REG & ACCES 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,591 F3 · kind: Represents RSUs of the reporting company withheld to satisfy tax withholding obligations in connection with the vesting of RSUs described in footnotes 1 and 2, exempt from Rule 16b-3. Read SEC document |
| September 30, 2022 Filed Oct 4, 2022 21:05 UTC |
Virkler DraytonINTERIM PRESIDENT, REG & ACCES
|
Exercise / conversionCommon Stock | 3,021 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-010245 · form4-10042022_021054.xml · nonDerivative · entry 2 Virkler Drayton · CIK 0001945604 · INTERIM PRESIDENT, REG & ACCES 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,595 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Each RSU was granted under the Certara, Inc. 2020 Incentive Plan and represents a right to receive one share of common stock or the cash equivalent thereof. One-third of the RSUs vested and were settled on September 30, 2022. The remaining two-thirds of the RSUs are scheduled to vest and settle on October 1, 2023 and October 1, 2024, subject to the continued service of the reporting person. Read SEC document |
| September 30, 2022 Filed Oct 4, 2022 21:05 UTC |
Virkler DraytonINTERIM PRESIDENT, REG & ACCES
|
Exercise / conversionCommon Stock | 10,574 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-010245 · form4-10042022_021054.xml · nonDerivative · entry 1 Virkler Drayton · CIK 0001945604 · INTERIM PRESIDENT, REG & ACCES 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,574 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSUs") was granted under the Certara, Inc. 2020 Incentive Plan and represents a right to receive one share of common stock or the cash equivalent thereof. The RSUs were granted on October 1, 2021 and cliff vested and settled on September 30, 2022. Read SEC document |
| August 19, 2022 Filed Aug 23, 2022 08:58 UTC |
McLean Stephen M.Director
|
PurchaseCommon Stock | 20,000 | $16.32 | $326,400.00 |
DisclosureSEC source: 0001415889-22-008945 · form4-08232022_050813.xml · nonDerivative · entry 1 McLean Stephen M. · CIK 0001834266 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,000 Read SEC document |
| August 17, 2022 Filed Aug 18, 2022 21:17 UTC |
Schemick Michael AndrewCHIEF FINANCIAL OFFICER
|
PurchaseCommon Stock | 25,000 | $16.64 | $416,000.00 |
DisclosureSEC source: 0001415889-22-008827 · form4-08182022_020814.xml · nonDerivative · entry 1 Schemick Michael Andrew · CIK 0001834300 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 517,870 F1 · price: The price reported is a weighted average price. The shares were purchased in multiple open market transactions at prices ranging from $16.57 to $16.67. The reporting person undertakes to provide, upon request, to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares purchased and the prices at which the transaction was effected. Read SEC document |
| August 16, 2022 Filed Aug 17, 2022 17:00 UTC |
SLAINE MASON PDirector
|
SaleCommon Stock | 182,475 | $17.38 | $3,171,415.50 |
DisclosureSEC source: 0001104659-22-092229 · tm2223687-1_4seq1.xml · nonDerivative · entry 1 SLAINE MASON P · CIK 0001079093 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 910,322 F1 · price: This amount represents the $17.75 public offering price per share of common stock of Certara, Inc., less the underwriting discount of $0.37 per share. Read SEC document |
| August 16, 2022 Filed Aug 17, 2022 21:01 UTC |
EQT Avatar Parent L.P.10% owner
EQT Avatar Parent GP LLC10% owner
EQT Fund Management S.a r.l.10% owner
|
SaleCommon Stock | 6,004,418 | $17.38 | $104,356,784.84 |
DisclosureSEC source: 0001104659-22-092231 · tm2223687-2_4seq1.xml · nonDerivative · entry 1 EQT Avatar Parent L.P. · CIK 0001715533 · 10% owner EQT Avatar Parent GP LLC · CIK 0001833933 · 10% owner EQT Fund Management S.a r.l. · CIK 0001834239 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Held by EQT Avatar Parent L.P. Disclosed balance after: 29,954,521 F1 · price: This amount represents the $17.75 public offering price per share of common stock of Certara, Inc., less the underwriting discount of $0.37 per share. F2 · ownership.nature: Consists of shares of common stock held directly by EQT Avatar Parent L.P. ("EQT Investor"). EQT Avatar Parent GP LLC ("Avatar Parent GP") is the general partner of the EQT Investor. Several investment vehicles collectively make up the fund known as "EQT VII." EQT VII owns 100% of the membership interests in Avatar Parent GP. EQT Fund Management S.a r.l. ("EFMS") has exclusive responsibility for the management and control of the business and affairs of investment vehicles which constitute the majority of the total commitments to EQT VII. As such, EFMS has the power to control Avatar Parent GP's voting and investment decisions and may be deemed to have beneficial ownership of the securities held by the EQT Investor. Read SEC document |
| August 16, 2022 Filed Aug 18, 2022 21:12 UTC |
SMITH PATRICK FPRESIDENT, INTEGRATED DRUG DEV
|
SaleCommon Stock | 10,000 | $17.71 | $177,100.00 |
DisclosureSEC source: 0001415889-22-008824 · form4-08182022_020839.xml · nonDerivative · entry 1 SMITH PATRICK F · CIK 0001890360 · PRESIDENT, INTEGRATED DRUG DEV 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,490 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 11, 2022. Read SEC document |
| August 01, 2022 Filed Aug 2, 2022 17:08 UTC |
SHERMAN NICOLETTE DCHIEF HUMAN RESOURCES OFFICER
|
Tax withholdingCommon Stock | 1,755 | $22.99 | $40,347.45 |
DisclosureSEC source: 0001415889-22-008129 · form4-08022022_020805.xml · nonDerivative · entry 2 SHERMAN NICOLETTE D · CIK 0001872604 · CHIEF HUMAN RESOURCES OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,808 F2 · shares: Represents RSUs withheld to satisfy the tax withholding obligations in connection with the vesting and settlement of 5,513 RSUs. The RSUs were granted on August 1, 2021, subject to one year cliff vesting. Read SEC document |
| August 01, 2022 Filed Aug 2, 2022 17:08 UTC |
SHERMAN NICOLETTE DCHIEF HUMAN RESOURCES OFFICER
|
Tax withholdingCommon Stock | 1,057 | $22.99 | $24,300.43 |
DisclosureSEC source: 0001415889-22-008129 · form4-08022022_020805.xml · nonDerivative · entry 1 SHERMAN NICOLETTE D · CIK 0001872604 · CHIEF HUMAN RESOURCES OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,563 F1 · shares: Represents restricted stock units ("RSUs") withheld to satisfy the tax withholding obligations in connection with the vesting and settlement of 3,369 RSUs, previously granted to the reporting person on August 1, 2021. The remaining two-thirds of the RSUs are scheduled to vest and settle in two equal installments on August 1, 2023 and August 1, 2024. Read SEC document |
| July 21, 2022 Filed Jul 22, 2022 20:36 UTC |
Crane Rosemary ADirector
|
GrantRestricted Stock Units · Derivative | 9,324 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-007919 · form4-07222022_010703.xml · derivative · entry 1 Crane Rosemary A · CIK 0001443343 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,324 Underlying: Common Stock · 9,324 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock. F2 · shares: Represents 9,324 RSUs granted under the Certara Inc. 2020 Incentive Plan that will entitle the reporting person to receive one share of the Issuer's Common Stock per RSU. The RSUs will vest on the earlier of the one-year anniversary of the date of grant or the date of the Issuer's next annual shareholder meeting. F3 · derivative.exercise_date: The RSUs will vest on the earlier of the one-year anniversary of the date of grant or the date of the Issuer's next annual shareholder meeting. F3 · derivative.expiration_date: The RSUs will vest on the earlier of the one-year anniversary of the date of grant or the date of the Issuer's next annual shareholder meeting. Read SEC document |
| July 13, 2022 Filed Jul 15, 2022 20:35 UTC |
BROSHY ERANDirector
|
GrantRestricted Stock Units · Derivative | 9,360 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-007690 · form4-07152022_010709.xml · derivative · entry 1 BROSHY ERAN · CIK 0001256230 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,360 Underlying: Common Stock · 9,360 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock. F2 · shares: Represents 9,360 RSUs granted under the Certara Inc. 2020 Incentive Plan that will entitle the reporting person to receive one share of the Issuer's Common Stock per RSU. The RSUs will vest on the earlier of the one-year anniversary of the date of grant or the date of the Issuer's next annual shareholder meeting. F3 · derivative.exercise_date: The RSUs will vest on the earlier of the one-year anniversary of the date of grant or the date of the Issuer's next annual shareholder meeting. F3 · derivative.expiration_date: The RSUs will vest on the earlier of the one-year anniversary of the date of grant or the date of the Issuer's next annual shareholder meeting. Read SEC document |
| July 01, 2022 Filed Jul 5, 2022 20:49 UTC |
Aspbury RobertPRESIDENT, SIMCYP
|
Tax withholdingCommon Stock | 884 | $21.46 | $18,970.64 |
DisclosureSEC source: 0001415889-22-007359 · form4-07052022_010705.xml · nonDerivative · entry 1 Aspbury Robert · CIK 0001834221 · PRESIDENT, SIMCYP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 275,215 F1 · shares: Represents restricted stock units ("RSU") withheld to satisfy tax withholding obligations in connection with the vesting and settlement of 1,831 RSUs, previously granted to the reporting person on July 1, 2021. The remaining two-thirds of the RSUs are scheduled to vest and settle in two equal installments on July 1, 2023 and July 1, 2024. Read SEC document |
| June 08, 2022 Filed Jun 9, 2022 20:44 UTC |
SMITH PATRICK FPRESIDENT, INTEGRATED DRUG DEV
|
SaleCommon Stock | 10,000 | $19.16 | $191,600.00 |
DisclosureSEC source: 0001415889-22-006381 · form4-06092022_010628.xml · nonDerivative · entry 1 SMITH PATRICK F · CIK 0001890360 · PRESIDENT, INTEGRATED DRUG DEV 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 88,490 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2022. Read SEC document |
| June 02, 2022 Filed Jun 3, 2022 16:29 UTC |
SLAINE MASON PDirector
|
SaleCommon Stock | 50,000 | $19.52 | $976,000.00 |
DisclosureSEC source: 0001415889-22-006114 · form4-06032022_010641.xml · nonDerivative · entry 3 SLAINE MASON P · CIK 0001079093 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,092,797 F3 · price: This transaction was executed in multiple trades at prices ranging from $19.42 to $19.66. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| June 02, 2022 Filed Jun 3, 2022 16:29 UTC |
SLAINE MASON PDirector
|
SaleCommon Stock | 100,000 | $19.59 | $1,959,000.00 |
DisclosureSEC source: 0001415889-22-006114 · form4-06032022_010641.xml · nonDerivative · entry 2 SLAINE MASON P · CIK 0001079093 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,142,797 F2 · price: This transaction was executed in multiple trades at prices ranging from $19.42 to $19.75. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| June 02, 2022 Filed Jun 3, 2022 16:29 UTC |
SLAINE MASON PDirector
|
SaleCommon Stock | 100,000 | $19.55 | $1,955,000.00 |
DisclosureSEC source: 0001415889-22-006114 · form4-06032022_010641.xml · nonDerivative · entry 1 SLAINE MASON P · CIK 0001079093 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,242,797 F1 · price: This transaction was executed in multiple trades at prices ranging from $19.23 to $19.83. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 31, 2022 Filed Jun 1, 2022 22:34 UTC |
EQT Avatar Parent L.P.10% owner
EQT Avatar Parent GP LLC10% owner
EQT Fund Management S.a r.l.10% owner
|
SaleCommon Stock | 1,500,000 | $19.00 | $28,500,000.00 |
DisclosureSEC source: 0001104659-22-067234 · tm2217488-1_4seq1.xml · nonDerivative · entry 1 EQT Avatar Parent L.P. · CIK 0001715533 · 10% owner EQT Avatar Parent GP LLC · CIK 0001833933 · 10% owner EQT Fund Management S.a r.l. · CIK 0001834239 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · Held by EQT Avatar Parent L.P. Disclosed balance after: 35,958,939 F1 · ownership.nature: Consists of shares of common stock held directly by EQT Avatar Parent L.P. ("EQT Investor"). EQT Avatar Parent GP LLC ("Avatar Parent GP") is the general partner of the EQT Investor. Several investment vehicles collectively make up the fund known as "EQT VII." EQT VII owns 100% of the membership interests in Avatar Parent GP. EQT Fund Management S.a r.l. ("EFMS") has exclusive responsibility for the management and control of the business and affairs of investment vehicles which constitute the majority of the total commitments to EQT VII. As such, EFMS has the power to control Avatar Parent GP's voting and investment decisions and may be deemed to have beneficial ownership of the securities held by the EQT Investor. Read SEC document |
| May 17, 2022 Filed May 18, 2022 16:22 UTC |
SLAINE MASON PDirector
|
GrantRestricted Stock Units · Derivative | 9,067 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-005236 · form4-05182022_010518.xml · derivative · entry 2 SLAINE MASON P · CIK 0001079093 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,067 Underlying: Common Stock · 9,067 shares Expires not disclosed F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock. F3 · shares: Represents 9,067 RSUs granted under the Certara Inc. 2020 Incentive Plan that will entitle the reporting person to receive one share of the Issuer's Common Stock per RSU. The RSUs will vest on the earlier of the one-year anniversary of the date of grant or the date of the Company's next annual shareholder meeting. The reporting person has reported prior awards of RSUs in Table 1 of Form 4. F4 · derivative.exercise_date: The RSUs will vest on the earlier of the one-year anniversary of the date of grant or the date of the Company's next annual shareholder meeting. F4 · derivative.expiration_date: The RSUs will vest on the earlier of the one-year anniversary of the date of grant or the date of the Company's next annual shareholder meeting. Read SEC document |
| May 17, 2022 Filed May 18, 2022 20:37 UTC |
Collins CynthiaDirector
|
GrantRestricted Stock Units · Derivative | 9,067 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-005245 · form4-05182022_010540.xml · derivative · entry 2 Collins Cynthia · CIK 0001405692 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,067 Underlying: Common Stock · 9,067 shares Expires not disclosed F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock. F3 · shares: Represents 9,067 RSUs granted under the Certara Inc. 2020 Incentive Plan that will entitle the reporting person to receive one share of the Issuer's Common Stock per RSU. The RSUs will vest on the earlier of the one-year anniversary of the date of grant or the date of the Company's next annual shareholder meeting. The reporting person has reported prior awards of RSUs in Table 1 of Form 4. F4 · derivative.exercise_date: The RSUs will vest on the earlier of the one-year anniversary of the date of grant or the date of the Company's next annual shareholder meeting. F4 · derivative.expiration_date: The RSUs will vest on the earlier of the one-year anniversary of the date of grant or the date of the Company's next annual shareholder meeting. Read SEC document |
| May 17, 2022 Filed May 18, 2022 20:42 UTC |
WALSH MATTHEW MDirector
|
GrantRestricted Stock Units · Derivative | 9,067 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-005247 · form4-05182022_010541.xml · derivative · entry 2 WALSH MATTHEW M · CIK 0001269428 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,067 Underlying: Common Stock · 9,067 shares Expires not disclosed F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock. F3 · shares: Represents 9,067 RSUs granted under the Certara Inc. 2020 Incentive Plan that will entitle the reporting person to receive one share of the Issuer's Common Stock per RSU. The RSUs will vest on the earlier of the one-year anniversary of the date of grant or the date of the Company's next annual shareholder meeting. The reporting person has reported prior awards of RSUs in Table 1 of Form 4. F4 · derivative.exercise_date: The RSUs will vest on the earlier of the one-year anniversary of the date of grant or the date of the Company's next annual shareholder meeting. F4 · derivative.expiration_date: The RSUs will vest on the earlier of the one-year anniversary of the date of grant or the date of the Company's next annual shareholder meeting. Read SEC document |
| May 17, 2022 Filed May 18, 2022 20:28 UTC |
CASHMAN JAMES E IIIDirector
|
GrantRestricted Stock Units · Derivative | 9,067 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-005238 · form4-05182022_010551.xml · derivative · entry 2 CASHMAN JAMES E III · CIK 0001199440 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,067 Underlying: Common Stock · 9,067 shares Expires not disclosed F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock. F3 · shares: Represents 9,067 RSUs granted under the Certara Inc. 2020 Incentive Plan that will entitle the reporting person to receive one share of the Issuer's Common Stock per RSU. The RSUs will vest on the earlier of the one-year anniversary of the date of grant or the date of the Company's next annual shareholder meeting. The reporting person has reported prior awards of RSUs in Table 1 of Form 4. F4 · derivative.exercise_date: The RSUs will vest on the earlier of the one-year anniversary of the date of grant or the date of the Company's next annual shareholder meeting. F4 · derivative.expiration_date: The RSUs will vest on the earlier of the one-year anniversary of the date of grant or the date of the Company's next annual shareholder meeting. Read SEC document |
| May 17, 2022 Filed May 18, 2022 20:33 UTC |
Killefer NancyDirector
|
GrantRestricted Stock Units · Derivative | 9,067 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-005243 · form4-05182022_010554.xml · derivative · entry 2 Killefer Nancy · CIK 0001584637 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,067 Underlying: Common Stock · 9,067 shares Expires not disclosed F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock. F3 · shares: Represents 9,067 RSUs granted under the Certara Inc. 2020 Incentive Plan that will entitle the reporting person to receive one share of the Issuer's Common Stock per RSU. The RSUs will vest on the earlier of the one-year anniversary of the date of grant or the date of the Company's next annual shareholder meeting. The reporting person has reported prior awards of RSUs in Table 1 of Form 4. F4 · derivative.exercise_date: The RSUs will vest on the earlier of the one-year anniversary of the date of grant or the date of the Company's next annual shareholder meeting. F4 · derivative.expiration_date: The RSUs will vest on the earlier of the one-year anniversary of the date of grant or the date of the Company's next annual shareholder meeting. Read SEC document |
| April 04, 2022 Filed Apr 5, 2022 20:26 UTC |
SMITH PATRICK FPRESIDENT, INTEGRATED DRUG DEV
|
SaleCommon Stock | 3,352 | $22.29 | $74,716.08 |
DisclosureSEC source: 0001415889-22-003827 · form4-04052022_010425.xml · nonDerivative · entry 2 SMITH PATRICK F · CIK 0001890360 · PRESIDENT, INTEGRATED DRUG DEV 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,490 F3 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 11, 2021. F4 · balance_after: The total reported in Column 5 includes 85,091 shares of common stock and 13,399 RSUs, each of which was previously reported in Table 1 of Form 4. Does not include 25,939 newly-awarded RSUs which are reported in Table II. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 16:29 UTC |
SHERMAN NICOLETTE DCHIEF HUMAN RESOURCES OFFICER
|
GrantRestricted Stock Units · Derivative | 11,972 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-22-003829 · form4-04052022_010456.xml · derivative · entry 1 SHERMAN NICOLETTE D · CIK 0001872604 · CHIEF HUMAN RESOURCES OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,972 Underlying: Common Stock · 11,972 shares Expires 2025-04-01 F1 · derivative.exercise_price: Each restricted stock unit ("RSU") is granted under the Certara, Inc. 2020 Incentive Plan and represents a right to receive one share of common stock or the cash equivalent thereof. The reporting person has reported prior awards of RSUs in Table 1 of Form 4. F2 · derivative.exercise_date: The RSUs will vest and settle in three equal installments on April 1, 2023, April 1, 2024 and April 1, 2025. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.